Evolution of an HIV glycan–dependent broadly neutralizing antibody epitope through immune escape-Reference-Cited by-同舟云学术

Evolution of an HIV glycan–dependent broadly neutralizing antibody epitope through immune escape

Published:2012-10-21 Issue:11 Volume:18 Page:1688-1692
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Moore Penny L,Gray Elin S,Wibmer C Kurt,Bhiman Jinal N,Nonyane Molati,Sheward Daniel J,Hermanus Tandile,Bajimaya Shringkhala,Tumba Nancy L,Abrahams Melissa-Rose,Lambson Bronwen E,Ranchobe Nthabeleng,Ping Lihua,Ngandu Nobubelo,Karim Quarraisha Abdool,Karim Salim S Abdool,Swanstrom Ronald I,Seaman Michael S,Williamson Carolyn,Morris Lynn

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/nm.2985.pdf

Reference36 articles.

1. Haynes, B.F. & Montefiori, D.C. Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidates. Expert Rev. Vaccines 5, 347–363 (2006).

2. Hu, S.L. & Stamatatos, L. Prospects of HIV Env modification as an approach to HIV vaccine design. Curr. HIV Res. 5, 507–513 (2007).

3. Phogat, S. & Wyatt, R. Rational modifications of HIV-1 envelope glycoproteins for immunogen design. Curr. Pharm. Des. 13, 213–227 (2007).

4. Li, Y. et al. Analysis of neutralization specificities in polyclonal sera derived from human immunodeficiency virus type 1–infected individuals. J. Virol. 83, 1045–1059 (2009).

5. Sather, D.N. et al. Factors associated with the development of cross-reactive neutralizing antibodies during human immunodeficiency virus type 1 infection. J. Virol. 83, 757–769 (2009).

Cited by 268 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HIV-1 Gag, Pol, and Env diversified with limited adaptation since the 1980s;mBio;2024-03-13

2. Genetic signatures in the highly virulent subtype B HIV-1 conferring immune escape to V1/V2 and V3 broadly neutralizing antibodies;2024-03-13

3. Broadly neutralizing antibodies targeting HIV: Progress and challenges;Clinical Immunology;2023-12

4. Dynamics and durability of HIV-1 neutralization are determined by viral replication;Nature Medicine;2023-11

5. ‘Immunization during ART and ATI for HIV-1 vaccine discovery/development’;Current Opinion in HIV and AIDS;2023-09-08